These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2560915)

  • 21. Efficacy of three inactivated vaccines against bluetongue virus serotype 8 in sheep.
    Eschbaumer M; Hoffmann B; König P; Teifke JP; Gethmann JM; Conraths FJ; Probst C; Mettenleiter TC; Beer M
    Vaccine; 2009 Jun; 27(31):4169-75. PubMed ID: 19406189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune response of mice and sheep to bluetongue virus inactivated by gamma irradiation.
    Campbell CH; Barber TL; Knudsen RC; Swaney LM
    Prog Clin Biol Res; 1985; 178():639-47. PubMed ID: 2989913
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protective efficacy of Bluetongue virus-like and subvirus-like particles in sheep: presence of the serotype-specific VP2, independent of its geographic lineage, is essential for protection.
    Stewart M; Dovas CI; Chatzinasiou E; Athmaram TN; Papanastassopoulou M; Papadopoulos O; Roy P
    Vaccine; 2012 Mar; 30(12):2131-9. PubMed ID: 22285887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inactivated bluetongue virus vaccine in lambs: differential serological responses related to breed.
    Berry LJ; Osburn BI; Stott JL; Farver T; Heron B; Patton W
    Vet Res Commun; 1982 May; 5(3):289-93. PubMed ID: 6287706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of a neutralizing epitope shared by bluetongue virus serotypes 2 and 13.
    Ristow S; Leendersten L; Gorham J; Yilma T
    J Virol; 1988 Jul; 62(7):2502-4. PubMed ID: 2453681
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Application of bluetongue Disabled Infectious Single Animal (DISA) vaccine for different serotypes by VP2 exchange or incorporation of chimeric VP2.
    Feenstra F; Pap JS; van Rijn PA
    Vaccine; 2015 Feb; 33(6):812-8. PubMed ID: 25510389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An inactivated vaccine for the control of bluetongue virus serotype 16 infection in sheep in Italy.
    Savini G; Ronchi GF; Leone A; Ciarelli A; Migliaccio P; Franchi P; Mercante MT; Pini A
    Vet Microbiol; 2007 Sep; 124(1-2):140-6. PubMed ID: 17499459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vaccines for bluetongue and other orbiviruses from a regulatory viewpoint.
    Strating A
    Prog Clin Biol Res; 1985; 178():627-9. PubMed ID: 2989911
    [No Abstract]   [Full Text] [Related]  

  • 29. Evaluation of cross-protection of bluetongue virus serotype 4 with other serotypes in sheep.
    Zulu GB; Venter EH
    J S Afr Vet Assoc; 2014 Oct; 85(1):1041. PubMed ID: 25686101
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiidiotypic antibody mimicry of a bluetongue virus neutralizing antigen.
    Grieder FB; Schultz KT
    J Immunol; 1990 Apr; 144(7):2627-31. PubMed ID: 1690772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bluetongue virus: comparative evaluation of enzyme-linked immunosorbent assay, immunodiffusion, and serum neutralization for detection of viral antibodies.
    Poli G; Stott J; Liu YS; Manning JS
    J Clin Microbiol; 1982 Jan; 15(1):159-62. PubMed ID: 6313740
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of a monoclonal antibody blocking ELISA for the detection of group-specific antibodies to bluetongue virus in experimental and field sera.
    Lunt RA; White JR; Blacksell SD
    J Gen Virol; 1988 Nov; 69 ( Pt 11)():2729-40. PubMed ID: 2846758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and serological outcome following the simultaneous inoculation of three bluetongue virus types into sheep.
    Jeggo MH; Wardley RC; Taylor WP
    Res Vet Sci; 1984 Nov; 37(3):368-70. PubMed ID: 6097969
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of a quadrivalent modified-live bluetongue virus vaccine in wildlife species.
    McConnell S; Morrill JC; Livingston CW
    Prog Clin Biol Res; 1985; 178():631-8. PubMed ID: 2989912
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new bluetongue virus serotype isolated in Kenya.
    Davies FG; Mungai JN; Pini A
    Vet Microbiol; 1992 Apr; 31(1):25-32. PubMed ID: 1319624
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunobiology of bluetongue virus.
    Schultz KT; Grieder FB
    Vet Immunol Immunopathol; 1987 May; 15(1-2):115-27. PubMed ID: 3039718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Strong protection induced by an experimental DIVA subunit vaccine against bluetongue virus serotype 8 in cattle.
    Anderson J; Hägglund S; Bréard E; Riou M; Zohari S; Comtet L; Olofson AS; Gélineau R; Martin G; Elvander M; Blomqvist G; Zientara S; Valarcher JF
    Vaccine; 2014 Nov; 32(49):6614-21. PubMed ID: 25312275
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monoclonal antibodies and bluetongue virus diagnosis.
    Anderson J
    Prog Clin Biol Res; 1985; 178():497-504. PubMed ID: 2989891
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of the serotype-specific and group-specific antigens of bluetongue virus.
    Huismans H; Erasmus BJ
    Onderstepoort J Vet Res; 1981 Jun; 48(2):51-8. PubMed ID: 6273773
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antigenic topography of bluetongue virus 17.
    Grieder FB; Schultz KT
    Microb Pathog; 1990 Apr; 8(4):299-303. PubMed ID: 1696679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.